Cargando…

Structure–Function Relationship of Retinal Ganglion Cells in Multiple Sclerosis

The retinal ganglion cells (RGC) may be considered an easily accessible pathophysiological site of degenerative processes in neurological diseases, such as the RGC damage detectable in multiple sclerosis (MS) patients with (HON) and without a history of optic neuritis (NON). We aimed to assess and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Nosairy, Khaldoon O., Horbrügger, Marc, Schippling, Sven, Wagner, Markus, Haghikia, Aiden, Pawlitzki, Marc, Hoffmann, Michael B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037992/ https://www.ncbi.nlm.nih.gov/pubmed/33810342 http://dx.doi.org/10.3390/ijms22073419

Ejemplares similares

MS optic neuritis-induced long-term structural changes within the visual pathway
por: Pawlitzki, Marc, et al.
Publicado: (2020)

Functional and structural readouts for early detection of retinal involvement in multiple sclerosis
por: Al-Nosairy, Khaldoon O., et al.
Publicado: (2023)

Optical Coherence Tomography as a Biomarker for Differential Diagnostics in Nystagmus: Ganglion Cell Layer Thickness Ratio
por: Al-Nosairy, Khaldoon O., et al.
Publicado: (2022)

Non-invasive electrophysiology in glaucoma, structure and function—a review
por: Al-Nosairy, Khaldoon O., et al.
Publicado: (2021)

Multiple sclerosis and nutrition: back to the future?
por: Gold, Ralf, et al.
Publicado: (2020)

Anatomically constrained tractography facilitates biologically plausible fiber reconstruction of the optic radiation in multiple sclerosis
por: Horbruegger, M., et al.
Publicado: (2019)

A three-year longitudinal study of retinal function and structure in patients with multiple sclerosis
por: Hanson, James V. M., et al.
Publicado: (2021)

Functional Dynamics of Deafferented Early Visual Cortex in Glaucoma
por: Prabhakaran, Gokulraj T., et al.
Publicado: (2021)

PARP-1 deregulation in multiple sclerosis
por: Meira, Maria, et al.
Publicado: (2019)

Western lifestyle and immunopathology of multiple sclerosis
por: Matveeva, Olga, et al.
Publicado: (2018)

Comparison of DTL and gold cup skin electrodes for recordings of the multifocal electroretinogram
por: Eckermann, Theresa, et al.
Publicado: (2022)

Effects of repetitive twice-weekly transcranial direct current stimulations on fatigue and fatigability in people with multiple sclerosis
por: Linnhoff, Stefanie, et al.
Publicado: (2023)

Commentary: Outer Retinal Dysfunction on Multifocal Electroretinography May Help Differentiating Multiple Sclerosis From Neuromyelitis Optica Spectrum Disorder
por: Hanson, James V. M., et al.
Publicado: (2020)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Environmental factors in autoimmune diseases and their role in multiple sclerosis
por: Jörg, Stefanie, et al.
Publicado: (2016)

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
por: Wurm, Hannah, et al.
Publicado: (2020)

Combined Multi-Modal Assessment of Glaucomatous Damage With Electroretinography and Optical Coherence Tomography/Angiography
por: Al-Nosairy, Khaldoon O., et al.
Publicado: (2020)

Mapping Visual Field Defects With fMRI – Impact of Approach and Experimental Conditions
por: Prabhakaran, Gokulraj T., et al.
Publicado: (2021)

Propionic acid beneficially modifies osteoporosis biomarkers in patients with multiple sclerosis
por: Duscha, Alexander, et al.
Publicado: (2022)

Lower Serum Zinc Levels in Patients with Multiple Sclerosis Compared to Healthy Controls
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Immunmodulatorische Therapien bei Multipler Sklerose in der Pandemie
por: Pawlitzki, Marc, et al.
Publicado: (2021)

Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis
por: Pfeuffer, Steffen, et al.
Publicado: (2021)

Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Rolfes, Leoni, et al.
Publicado: (2020)

Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Huntemann, Niklas, et al.
Publicado: (2021)

CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Altered Perception of the Bistable Motion Quartet in Albinism
por: Al-Nosairy, Khaldoon O., et al.
Publicado: (2023)

VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography
por: Oberwahrenbrock, Timm, et al.
Publicado: (2012)

Optimizing treatment success in multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Optic Neuritis and Retinal Ganglion Cell Loss in a Chronic Murine Model of Multiple Sclerosis
por: Quinn, Thomas A., et al.
Publicado: (2011)

Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment
por: Rolfes, Leoni, et al.
Publicado: (2021)

The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
por: Hammer, Anna, et al.
Publicado: (2018)

Understanding the impacts of COVID-19 pandemic in people with multiple sclerosis treated with ocrelizumab
por: Pedotti, Rosetta, et al.
Publicado: (2021)

Structure/Function relationship and retinal ganglion cells counts to discriminate glaucomatous damages
por: Distante, Pietro, et al.
Publicado: (2015)

Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
por: Rolfes, Leoni, et al.
Publicado: (2019)

Combinations of Susceptibility Genes Are Associated with Higher Risk for Multiple Sclerosis and Imply Disease Course Specificity
por: Akkad, Denis A., et al.
Publicado: (2015)

Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple Sclerosis
por: Vermersch, Patrick, et al.
Publicado: (2019)

Systemic Mesenchymal Stem Cell Treatment Mitigates Structural and Functional Retinal Ganglion Cell Degeneration in a Mouse Model of Multiple Sclerosis
por: Gramlich, Oliver W., et al.
Publicado: (2020)

Longitudinal Optical Coherence Tomography Measurement of Retinal Ganglion Cell and Nerve Fiber Layer to Assess Benign Course in Multiple Sclerosis
por: Al-Hawasi, Abbas, et al.
Publicado: (2023)

Rapid Campimetry—A Novel Screening Method for Glaucoma Diagnosis
por: Müller, Fabian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ijk5f05s7gjgkvv0o3jh1povem